Research output

Publications

Selected papers and the complete publication record of the group — from capillary electrophoresis and inherited metabolic disorders to clinical lipidomics and multi-omics.

132 papers in record 1998–2026 years of research Google Scholar ↗ PubMed ↗ Web of Science ↗

Featured publications

Selected papers representing our main research directions

A curated selection highlighting our work in lipidomics, metabolomics, clinical mass spectrometry and translational laboratory medicine. For the most up-to-date record, see our public profiles above.

Data analysis

Best practices and tools in R and Python for statistical processing and visualization of lipidomics and metabolomics data

Idkowiak J, et al.
Nature Communications. 2025;16:8714

A practical high-impact methodological paper providing open tools and recommendations for processing, statistical analysis and visualization of lipidomics and metabolomics data.

DOI
Clinical lipidomics

Lipidomic profiling of human serum enables detection of pancreatic cancer

Wolrab D, et al.
Nature Communications. 2022;13:124

A landmark serum lipidomics study demonstrating the potential of lipid profiles for cancer detection and translational biomarker discovery.

DOI
Cardiovascular lipidomics

Ceramide-based risk score: a novel laboratory tool for cardiovascular risk stratification in hyperuricemia and gout

Kvasnička A, Friedecký D, Piskláková B, et al.
Vascular Pharmacology. 2025;159:107495

Shows how ceramide-based lipid scores may support laboratory-based cardiovascular risk stratification in clinically defined patient cohorts.

DOI
Laboratory medicine

Clinical lipidomics in the era of the big data

Kvasnička A, et al.
Clinical Chemistry and Laboratory Medicine. 2023;61:587–598

Positions lipidomics as an emerging discipline within data-driven laboratory medicine and translational diagnostics.

DOI
Inherited metabolic disorders

Rapid and efficient LC-MS/MS diagnosis of inherited metabolic disorders: a semi-automated workflow for analysis of organic acids, acylglycines, and acylcarnitines in urine

Piskláková B, et al.
Clinical Chemistry and Laboratory Medicine. 2023;61:2017–2027

Robust, semi-automated LC-MS/MS workflows for clinical diagnostics of inherited metabolic disorders.

DOI
Method development

Wide metabolite coverage LC-MS/MS assay for the diagnosis of inherited metabolic disorders in urine

Ivanovová E, et al.
Talanta. 2024;271:125699

A recent analytical study demonstrating broad metabolite coverage for diagnostic LC-MS/MS workflows in inherited metabolic disorders.

DOI
Inflammation — gout

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

Kvasnička A, Friedecký D, Brumarová R, et al.
Arthritis Research & Therapy. 2023;25:234

Demonstrates how lipidomics can distinguish clinically relevant disease phenotypes and treatment effects in inflammatory and metabolic disease.

DOI
Neurodegeneration — lipid metabolism

Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies

Olesová D, Dobešová D, Majerová P, et al.
Journal of Neuroinflammation. 2024;21:78

A translational lipidomics study linking lipid metabolism to neurodegenerative disease progression and neurofibrillary pathology.

DOI
Clinical metabolomics — laboratory medicine

A global perspective on the status of clinical metabolomics in laboratory medicine — a survey by the IFCC metabolomics working group

Fux E, Lenski M, Bendt AK, et al.
Clinical Chemistry and Laboratory Medicine. 2024;62:1950–1961

Connects the group with the international discussion on how metabolomics is entering clinical laboratory medicine.

DOI

The complete record

List of all publications

Browse the full archive by year or search across titles, authors and journals. Every entry links to its DOI where available.

132 papers

2026

6 papers
01

Acute Sodium Bicarbonate Supplementation in Finswimming: Performance, Stroke Mechanics, and Perceptual Responses

Michalica T, et al. · Journal of Human Kinetics , 2026

DOI
02

A hybrid RNA-based reporter assay for robust quantification of cytidine deaminase activity

Ligasová A, et al. · Nucleic Acids Research , 2026;54(11):gkag588

DOI
03

Derivatisation-free FIA-MS/MS assay for rapid simultaneous screening of atypical myopathy biomarkers and acylcarnitine profiles from dried blood spots

Kadláčková M, et al. · Analytical and Bioanalytical Chemistry , 2026

DOI
04

Long-Term Static Cultivation Alters Lipid Metabolism and Bioenergetic Capacity in A549 Cells

Durišová, et al. · International Journal of Molecular Sciences , 2026;27(8):3417

DOI
05

Aromatase Inhibitor Therapy Is Associated with Distinct Plasma Lipidomic Profiles in Postmenopausal Breast Cancer Patients

Arsic, et al. · International Journal of Molecular Sciences , 2026;27(4):1926

DOI
06

ABCA7 deficiency exacerbates glutamate excitotoxicity in Alzheimer's disease mice — a new pharmacological target for Glu-related neurotoxicity

Gorska, et al. · Progress in Neurobiology , 2026;259:102891

DOI

2025

12 papers
01

Best practices and tools in R and Python for statistical processing and visualization of lipidomics and metabolomics data

Idkowiak J, et al. · Nature Communications , 2025;16(1):8714

DOI
02

Ceramide-based risk score: a novel laboratory tool for cardiovascular risk stratification in hyperuricemia and gout

Kvasnička A, Friedecký D, Piskláková B, et al. · Vascular Pharmacology , 2025;159:107495

DOI
03

Cytidine and dCMP deaminases — current methods of activity analysis

Ligasová A, et al. · International Journal of Molecular Sciences , 2025;26(16):8045

DOI
04

Sex-dependent efficacy of sphingosine-1-phosphate receptor agonist FTY720 in mitigating Huntington's disease

Wu, et al. · Pharmacological Research , 2025;211:107557

DOI
05

Comparison of inflammatory biomarker levels in neurodegenerative proteinopathies: a case-control study

Cook, et al. · Journal of Neural Transmission , 2025;132(6):811–826

DOI
06

MInfer: bridging MetaboAnalyst and Jacobian analysis for metabolomic networks

Schwarzerová, et al. · Computer Methods and Programs in Biomedicine , 2025;263:108672

DOI
07

The kinetics of uracil-N-glycosylase distribution inside replication foci

Ligasová, et al. · Scientific Reports , 2025;15(1):3026

DOI
08

Horse with myopathy caused by consumption of box elder tree seedlings in the Czech Republic

Jahn, et al. · Equine Veterinary Education , 2025;37(5):e77–e84

DOI
09

Serum neopterin and mortality in lung cancer patients treated with immune checkpoint inhibitors

Spisarová, et al. · Journal of Thoracic Oncology , 2025;20(10)

10

Multi-omics insights into human brown and white adipose tissue: identifying novel regulators of thermogenesis

Petříšková, et al. · Diabetologia , 2025;68:S337–S338

11

Comprehensive metabolomic/lipidomic characterization of patients with mitochondrial ATP synthase, short-chain acyl-CoA dehydrogenase and combined variant deficiencies

Dobešová, et al. · Heliyon , 2025;11(4):e42797

DOI
12

Enhanced metabolomic predictions using concept drift analysis: identification and correction of confounding factors

Schwarzerová, et al. · Bioinformatics Advances , 2025;5(1):vbaf073

DOI

2024

11 papers
01

Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies

Olesová D, Dobešová D, Majerová P, et al. · Journal of Neuroinflammation , 2024;21(1):78

DOI
02

Patients with neurodegenerative proteinopathies exhibit altered tryptophan metabolism in the serum and cerebrospinal fluid

Kaleta, et al. · ACS Chemical Neuroscience , 2024;15(3):582–592

DOI
03

Parallel metabolomics and lipidomics of a PSMA/GCPII deficient mouse model reveal alteration of NAAG levels and brain lipid composition

Sedlák, et al. · ACS Chemical Neuroscience , 2024;15(7):1342–1355

DOI
04

A global perspective on the status of clinical metabolomics in laboratory medicine — a survey by the IFCC metabolomics working group

Fux E, Lenski M, Bendt AK, et al. · Clinical Chemistry and Laboratory Medicine , 2024;62(10):1950–1961

DOI
05

Assessing HCH isomer uptake in Alnus glutinosa: implications for phytoremediation and microbial response

Amirbekov, et al. · Scientific Reports , 2024;14(1):4187

DOI
06

Wide metabolite coverage LC-MS/MS assay for the diagnosis of inherited metabolic disorders in urine

Ivanovová E, et al. · Talanta , 2024;271:125699

DOI
07

Utilizing neurodegenerative markers for the diagnostic evaluation of amyotrophic lateral sclerosis

Klíčová, et al. · European Journal of Medical Research , 2024;29(1):31

DOI
08

Long-chain polyunsaturated fatty acid-containing phosphatidylcholines predict survival rate in patients after heart failure

Kvasnička, et al. · Heliyon , 2024;10(21):e39979

DOI
09

Adipokine levels of RBP4, resistin and nesfatin-1 in women diagnosed with gestational diabetes

Kučerová, et al. · Physiological Research , 2024;73(6):1037–1048

DOI
10

Aminoacylase 1 deficiency: case report on three affected siblings

Smolka, et al. · AME Case Reports , 2024;8

DOI
11

CERT score as a potential tool to predict cardiovascular risk in gout and hyperuricemia

Stibůrková, et al. · Arthritis & Rheumatology , 2024;76:2234–2235

2023

12 papers
01

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

Kvasnička A, Friedecký D, Brumarová R, et al. · Arthritis Research & Therapy , 2023;25(1):234

DOI
02

Clinical lipidomics in the era of the big data

Kvasnička A, et al. · Clinical Chemistry and Laboratory Medicine , 2023;61(4):587–598

DOI
03

From big data to better patient outcomes

Hulsen, et al. · Clinical Chemistry and Laboratory Medicine , 2023;61(4):580–586

DOI
04

Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: a prospective, open, cross-correlation study

Koníčková, et al. · Journal of Neurochemistry , 2023;167(2):168–182

DOI
05

A new technique for the analysis of metabolic pathways of cytidine analogues and cytidine deaminase activities in cells

Ligasová, et al. · Scientific Reports , 2023;13(1):20530

DOI
06

Rapid and efficient LC-MS/MS diagnosis of inherited metabolic disorders: a semi-automated workflow for analysis of organic acids, acylglycines, and acylcarnitines in urine

Piskláková B, et al. · Clinical Chemistry and Laboratory Medicine , 2023;61(11):2017–2027

DOI
07

Principal balances of compositional data for regression and classification using partial least squares

Nesrstová, et al. · Journal of Chemometrics , 2023;37(12):e3518

DOI
08

Multivariate independent component analysis identifies patients in newborn screening equally to adjusted reference ranges

Kouril, et al. · International Journal of Neonatal Screening , 2023;9(4):60

DOI
09

Determining thrombogenicity: using a modified thrombin generation assay to detect the level of thrombotic event risk in lupus anticoagulant-positive patients

Bradáčová, et al. · Biomedicines , 2023;11(12):3329

DOI
10

Metabolomic profiling confirms the key role of oxidative stress in the pathophysiology of Diamond-Blackfan anemia

Jahoda, et al. · Blood , 2023;142

DOI
11

Selective pivot logratio coordinates for partial least squares discriminant analysis modelling with applications in metabolomics

Štefelová, et al. · Stat , 2023;12(1):e592

DOI
12

Systematic comparison of advanced network analysis and visualization of lipidomics data

Schwarzerová, et al. · Bioinformatics and Biomedical Engineering (IWBBIO 2023), Part I , 2023;13919:378–389

DOI

2022

11 papers
01

Lipidomic profiling of human serum enables detection of pancreatic cancer

Wolrab D, et al. · Nature Communications , 2022;13(1):124

DOI
02

Biomarkers of neurodegenerative diseases: biology, taxonomy, clinical relevance, and current research status

Koníčková, et al. · Biomedicines , 2022;10(7):1760

DOI
03

Specific gut bacterial and fungal microbiota pattern in the first half of pregnancy is linked to the development of gestational diabetes mellitus in the cohort including obese women

Vavřečková, et al. · Frontiers in Endocrinology , 2022;13:970825

DOI
04

Lipidomic and metabolomic analysis reveals changes in biochemical pathways for non-small cell lung cancer tissues

Cífková, et al. · Biochimica et Biophysica Acta — Molecular and Cell Biology of Lipids , 2022;1867(2):159082

DOI
05

Metabolomic, lipidomic and proteomic characterisation of lipopolysaccharide-induced inflammation mouse model

Puriš, et al. · Neuroscience , 2022;496:165–178

DOI
06

Altered plasma, urine, and tissue profiles of sulfatides and sphingomyelins in patients with renal cell carcinoma

Jirásko, et al. · Cancers , 2022;14(19):4622

DOI
07

Dynamics of acylcarnitines, hypoglycin A, methylenecyclopropylglycine and their metabolites in a Kladruber stallion with atypical myopathy

Jahn, et al. · Veterinary Quarterly , 2022;42(1):183–191

DOI
08

Determination of thrombogenicity levels of various antiphospholipid antibodies by a modified thrombin generation assay in patients with suspected antiphospholipid syndrome

Bradáčová, et al. · International Journal of Molecular Sciences , 2022;23(16):8973

DOI
09

Combined targeted and untargeted profiling of HeLa cells deficient in purine de novo synthesis

Madrová, et al. · Metabolites , 2022;12(3):241

DOI
10

Targeted plasma lipidomics distinguishes patients with gout and hyperuricemia from controls

Stibůrková, et al. · Arthritis & Rheumatology , 2022;74:3598–3599

11

Metabolomic analysis of HeLa cells deficient in purine de novo synthesis

Madrová, et al. · Clinica Chimica Acta , 2022;530:S404–S405

DOI

2021

7 papers
01

Impact of newborn screening and early dietary management on clinical outcome of patients with long chain 3-hydroxyacyl-CoA dehydrogenase deficiency and medium chain acyl-CoA dehydrogenase deficiency — a retrospective nationwide study

Rucklová, et al. · Nutrients , 2021;13(9):2925

DOI
02

Metabolomic and lipidomic changes triggered by lipopolysaccharide-induced systemic inflammation in transgenic APdE9 mice

Puriš, et al. · Scientific Reports , 2021;11(1):13076

DOI
03

GM3 ganglioside linked to neurofibrillary pathology in a transgenic rat model for tauopathy

Olesová, et al. · International Journal of Molecular Sciences , 2021;22(22):12581

DOI
04

SLIDE — novel approach to apocrine sweat sampling for lipid profiling in healthy individuals

Kvasnička, et al. · International Journal of Molecular Sciences , 2021;22(15):8054

DOI
05

Novel LC-MS tools for diagnosing inborn errors of metabolism

Ivanovová, et al. · Microchemical Journal , 2021;170:106654

DOI
06

Evaluation of the determination of dabigatran, rivaroxaban, and apixaban in lupus anticoagulant-positive patients

Ulehlová, et al. · Diagnostics , 2021;11(11):2027

DOI
07

Plasma short-chain fatty acids and their derivatives in women with gestational diabetes mellitus

Ivanovová, et al. · Separations , 2021;8(10):188

DOI

2020

4 papers
01

CROP: correlation-based reduction of feature multiplicities in untargeted metabolomic data

Kouril, et al. · Bioinformatics , 2020;36(9):2941–2942

DOI
02

Cellwise outlier detection and biomarker identification in metabolomics based on pairwise log ratios

Walach, et al. · Journal of Chemometrics , 2020;34(1):e3182

DOI
03

Bayesian multiple hypotheses testing in compositional analysis of untargeted metabolomic data

de Sousa, et al. · Analytica Chimica Acta , 2020;1097:49–61

DOI
04

Global DNA methylation in rats' liver is not affected by hypercholesterolemic diet

Juříčková-Novotná, et al. · Physiological Research , 2020;69(2):347–352

DOI

2019

5 papers
01

Evaluation of the DOAC-Stop procedure by LC-MS/MS assays for determining the residual activity of dabigatran, rivaroxaban, and apixaban

Slavík, et al. · Clinical and Applied Thrombosis/Hemostasis , 2019;25:1076029619872556

DOI
02

Epidemiology of rare diseases detected by newborn screening in the Czech Republic

David, et al. · Central European Journal of Public Health , 2019;27(2):153–159

DOI
03

Impact of sample dimensionality on orthogonality metrics in comprehensive two-dimensional separations

Jacová, et al. · Analytica Chimica Acta , 2019;1064:138–149

DOI
04

Urease-immobilized magnetic microparticles in urine sample preparation for metabolomic analysis by gas chromatography-mass spectrometry

Jacová, et al. · Journal of Chromatography A , 2019;1605:360355

DOI
05

White adipose tissue response of obese mice to ambient oxygen restriction at thermoneutrality: response markers identified, but no WAT inflammation

Hoevenaars, et al. · Genes , 2019;10(5):359

DOI

2018

7 papers
01

Mass spectrometric analysis of purine de novo biosynthesis intermediates

Madrová, et al. · PLoS One , 2018;13(12):e0208947

DOI
02

Structural elucidation of novel biomarkers of known metabolic disorders based on multistage fragmentation mass spectra

Václavík, et al. · Journal of Inherited Metabolic Disease , 2018;41(3):407–414

DOI
03

Human white adipose tissue metabolome: current perspective

Kučera, et al. · Obesity , 2018;26(12):1870–1878

DOI
04

Newborn foal with atypical myopathy

Karlíková, et al. · Journal of Veterinary Internal Medicine , 2018;32(5):1768–1772

DOI
05

Multianalyte determination of NOACs using LC-MS/MS and comparison with functional coagulation assays

Slavík, et al. · Clinical Laboratory , 2018;64(10):1611–1621

DOI
06

Radio-sensitizing effects of VE-821 and beyond: distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells

Šalovská, et al. · PLoS One , 2018;13(7):e0199349

DOI
07

Toll-like receptor 7/8 ligand, S28463, suppresses Ascaris suum-induced allergic asthma in nonhuman primates

Camateros, et al. · American Journal of Respiratory Cell and Molecular Biology , 2018;58(1):55–65

DOI

2017

4 papers
01

Metabolic response of visceral white adipose tissue of obese mice exposed for 5 days to human room temperature compared to mouse thermoneutrality

van der Stelt, et al. · Frontiers in Physiology , 2017;8:179

DOI
02

Metabolic status of CSF distinguishes rats with tauopathy from controls

Karlíková, et al. · Alzheimer's Research & Therapy , 2017;9:78

DOI
03

Novel sulphur-containing imatinib metabolites found by untargeted LC-HRMS analysis

Vrobel, et al. · European Journal of Pharmaceutical Sciences , 2017;104:335–343

DOI
04

Sample-independent approach to normalize two-dimensional data for orthogonality evaluation using whole separation space scaling

Jacová, et al. · Journal of Chromatography A , 2017;1511:1–8

DOI

2016

9 papers
01

Metabolite profiling of the plasma and leukocytes of chronic myeloid leukemia patients

Karlíková, et al. · Journal of Proteome Research , 2016;15(9):3158–3166

DOI
02

Influence of mass resolving power in orbital ion-trap mass spectrometry-based metabolomics

Najdekr, et al. · Analytical Chemistry , 2016;88(23):11429–11435

DOI
03

Citrulline as a biomarker of gastrointestinal toxicity in patients with rectal carcinoma treated with chemoradiation

Zezulová, et al. · Clinical Chemistry and Laboratory Medicine , 2016;54(2):305–314

DOI
04

Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2′-deoxyuridine and 5-ethynyl-2′-deoxycytidine

Ligasová, et al. · Open Biology , 2016;6(1):150172

DOI
05

A lower dosage of imatinib is sufficient to maintain undetectable disease in patients with chronic myeloid leukemia with long-term low-grade toxicity of the treatment

Faber, et al. · Leukemia & Lymphoma , 2016;57(2):370–375

DOI
06

Equine atypical myopathy: a metabolic study

Karlíková, et al. · The Veterinary Journal , 2016;216:125–132

DOI
07

Normalization techniques for PARAFAC modeling of urine metabolomic data

Gardlo, et al. · Metabolomics , 2016;12(7):117

DOI
08

Ultrafast online SPE-MS/MS method for quantification of 3 tyrosine kinase inhibitors in human plasma

Vrobel, et al. · Therapeutic Drug Monitoring , 2016;38(4):516–524

DOI
09

Amlodipine plasma levels and side effects in patients with arterial hypertension

Kocianová, et al. · European Heart Journal , 2016;37:266

2015

4 papers
01

Oxidized phosphatidylcholines suggest oxidative stress in patients with medium-chain acyl-CoA dehydrogenase deficiency

Najdekr, et al. · Talanta , 2015;139:62–66

DOI
02

A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity

Ligasová, et al. · PLoS One , 2015;10(2):e0117459

DOI
03

Untargeted metabolomic analysis of urine samples in the diagnosis of some inherited metabolic disorders

Janečková, et al. · Biomedical Papers , 2015;159(4):582–585

DOI
04

Detailed study of imatinib metabolization using high-resolution mass spectrometry

Friedecký, et al. · Journal of Chromatography A , 2015;1409:173–181

DOI

2014

2 papers
01

Fenretinide prevents inflammation and airway hyperresponsiveness in a mouse model of allergic asthma

Kanagaratham, et al. · American Journal of Respiratory Cell and Molecular Biology , 2014;51(6):783–792

DOI
02

Influence of mass spectrometry resolution on metabolite coverage in plasma

Najdekr, et al. · CECE 2014: 11th International Interdisciplinary Meeting on Bioanalysis , 2014:92–93

2013

2 papers
01

A significant proportion of patients with chronic myeloid leukemia and suboptimal response according to European LeukemiaNet criteria have excellent prognosis without treatment change

Rohon, et al. · Biomedical Papers , 2013;157(2):181–188

DOI
02

Metabolomic techniques in biomedicine

Wojtowicz, et al. · Chemické listy , 2013;107(1):3–11

2012

5 papers
01

Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders

Janečková, et al. · Journal of Chromatography A , 2012;1226:11–17

DOI
02

Isotope dilution direct injection mass spectrometry method for determination of four tyrosine kinase inhibitors in human plasma

Micová, et al. · Talanta , 2012;93:307–313

DOI
03

Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting

Faber, et al. · Annals of Hematology , 2012;91(6):923–929

DOI
04

Analysis of cytokinin nucleotides by capillary zone electrophoresis with diode array and mass spectrometric detection in a recombinant enzyme in vitro reaction

Beres, et al. · Analytica Chimica Acta , 2012;751:176–181

DOI
05

High lapatinib plasma levels in breast cancer patients: risk or benefit?

Cízková, et al. · Tumori Journal , 2012;98(1):162–165

DOI

2011

1 paper
01

Analysis of nucleotides in dry blood spots

Baresova, et al. · Chemické listy , 2011;105(3):207–211

2010

7 papers
01

Flow injection analysis vs. ultra high performance liquid chromatography coupled with tandem mass spectrometry for determination of imatinib in human plasma

Micová, et al. · Clinica Chimica Acta , 2010;411(23–24):1957–1962

DOI
02

Lapatinib in breast cancer — the predictive significance of HER1 (EGFR), HER2, PTEN and PIK3CA genes and lapatinib plasma level assessment

Bouchalová, et al. · Biomedical Papers , 2010;154(4):281–288

DOI
03

Imatinib dose escalation in two patients with chronic myeloid leukemia, with low trough imatinib plasma levels measured at various intervals from the beginning of therapy and with suboptimal treatment response, leads to the achievement of higher plasma levels and major molecular response

Faber, et al. · International Journal of Hematology , 2010;91(5):897–902

DOI
04

Determination of tyrosine kinase inhibitors in human plasma by UHPLC-MS/MS

Micová, et al. · Chemické listy , 2010;104:S31–S34

05

Oligodendroglia from ADSL-deficient patient produce SAICAribotide and SAMP

Zídková, et al. · Molecular Genetics and Metabolism , 2010;101(2–3):286–288

DOI
06

Measurement of trough imatinib plasma levels in patients with CML does not significantly correlate with treatment response but may be successfully used in selected patients for dosage adjustment

Faber, et al. · Haematologica , 2010;95:343–344

07

Nucleotide analysis in blood spots

Baresova, et al. · Chemické listy , 2010;104:S3–S5

2009

1 paper
01

Capillary electrophoresis determination of thiopurine methyl transferase activity in erythrocytes

Tomková, et al. · Journal of Chromatography B , 2009;877(20–21):1943–1945

DOI

2008

3 papers
01

Imatinib plasma levels correlate with molecular response in CML patients

Faber, et al. · Haematologica , 2008;93:219–220

02

ITPase activity in dry blood spots is comparable with that in fresh erythrocytes

Tomková, et al. · Nucleosides, Nucleotides & Nucleic Acids , 2008;27(6–7):656–660

DOI
03

Determination of imatinib in plasma by high performance capillary electrophoresis

Faber, et al. · Haematologica , 2008;93:442–443

2007

4 papers
01

Capillary electrophoretic method for nucleotide analysis in cells: application on inherited metabolic disorders

Friedecký, et al. · Electrophoresis , 2007;28(3):373–380

DOI
02

Analysis of aminoimidazole ribosides by capillary electrophoresis: diagnosing defects in second part of purine biosynthetic pathway

Horník, et al. · Clinica Chimica Acta , 2007;376(1–2):184–189

DOI
03

Determination of ITPase activity by capillary electrophoresis

Friedecký, et al. · Clinical Chemistry , 2007;53(6):1164–1165

DOI
04

Spectral and electromigration characteristics of imidazole riboside

Vyskočilová, et al. · Chemické listy , 2007;101(3):250–254

2006

5 papers
01

Diagnosing AICA-ribosiduria by capillary electrophoresis

Horník, et al. · Journal of Chromatography B , 2006;843(1):15–19

DOI
02

Analysis of intracellular nucleotides by capillary electrophoresis — mass spectrometry

Friedecký, et al. · Nucleosides, Nucleotides & Nucleic Acids , 2006;25(9–11):1233–1236

DOI
03

Synthesis and mass spectrometric fragmentation characteristics of imidazole ribosides — analogs of intermediates of purine de novo synthetic pathway

Vyskočilová, et al. · Nucleosides, Nucleotides & Nucleic Acids , 2006;25(9–11):1237–1240

DOI
04

Analysis of aminoimidazole ribosides by capillary electrophoresis: diagnosing inborn errors of second part of purine de novo synthesis

Adam, et al. · Journal of Inherited Metabolic Disease , 2006;29:129

05

Screening for defects in purine de novo biosynthesis by TLC

Adam, et al. · Journal of Inherited Metabolic Disease , 2006;29:129

2005

1 paper
01

The involvement of cytokinin oxidase/dehydrogenase and zeatin reductase in regulation of cytokinin levels in pea (Pisum sativum L.) leaves

Gaudinová, et al. · Journal of Plant Growth Regulation , 2005;24(3):188–200

DOI

2004

1 paper
01

Analytical derivatization — a tool for determination of orotic acid

Husková, et al. · Journal of Chromatography B , 2004;799(2):303–309

DOI

2003

1 paper
01

High-throughput capillary electrophoretic method for determination of total aminothiols in plasma and urine

Lochman, et al. · Electrophoresis , 2003;24(7–8):1200–1207

DOI

2002

2 papers
01

Capillary electrophoresis for detection of inherited disorders of purine and pyrimidine metabolism: a selective approach

Friedecký, et al. · Electrophoresis , 2002;23(4):565–571

02

Screening method for inherited disorders of purine and pyrimidine metabolism by capillary electrophoresis with reversed electroosmotic flow

Adam, et al. · Journal of Chromatography B , 2002;767(2):333–340

DOI

2001

1 paper
01

Fast analysis of antibacterial isothiazolones by capillary electrophoresis

Barták, et al. · Journal of Chromatography B , 2001;758(2):323–325

DOI

2000

1 paper
01

Mass spectrometry for analysis of purine and pyrimidine compounds

Lemr, et al. · Purine and Pyrimidine Metabolism in Man X , 2000;486:399–403

1999

2 papers
01

Capillary electrophoresis for detection of inherited disorders of purine and pyrimidine metabolism

Adam, et al. · Clinical Chemistry , 1999;45(12):2086–2093

02

New techniques in diagnostics by capillary electrophoresis of hereditary disorders of purine and pyrimidine metabolism

Friedecký, et al. · Chemické listy , 1999;93(8):528–532

1998

1 paper
01

Study of cytokinin separation using capillary electrophoresis with cyclodextrin additives

Barták, et al. · Journal of Chromatography A , 1998;818(2):231–238

DOI

Collaborate with us

Join the group or start a collaboration.

We are open to motivated students, PhD candidates and clinical or research partners interested in translational omics, lipidomics, metabolomics and clinical LC-MS/MS.